December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Efficiency of various drugs in the prevention of Posterior Capsular Opacification (PCO): Preliminary study
Author Affiliations & Notes
  • MA Fragoso
    Cell Biology & Anatomy (R-124) Univ of Miami Sch of Med Miami FL
  • V Fernandez
    Ophthalmic Biophysics Center Bascom Palmer Eye Institute Miami FL
  • P Lamar
    Ophthalmic Biophysics Center Bascom Palmer Eye Institute Miami FL
  • M Willcox
    CRC for Eye Research and Technology Univ of New South Wales Sydney Australia
  • JM Parel
    Ophthalmic Biophysics Center Bascom Palmer Eye Institute Miami FL
  • Footnotes
    Commercial Relationships   M.A. Fragoso, None; V. Fernandez, None; P. Lamar, None; M. Willcox, None; J.M. Parel, None. Grant Identification: Henri and Flore Lesieur Foundation
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 431. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MA Fragoso, V Fernandez, P Lamar, M Willcox, JM Parel; Efficiency of various drugs in the prevention of Posterior Capsular Opacification (PCO): Preliminary study . Invest. Ophthalmol. Vis. Sci. 2002;43(13):431.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To assess the efficiency of various drugs in the prevention of PCO. Methods:12 NZW female rabbits (1.71±0.13 kg) were utilized in this study. Lens material was removed using the Phaco-Ersatz procedure involving the removal through a micro-capsulorhexis. A mixture of viscoelastic (1.4% sodium hyaluronate, SHA, Corneal SA, Paris) and drug was injected into an empty lens capsule, allowed to remain inside for 3 min, removed, rinsed with Balanced Saline Solution (BSS) and refilled with pure SHA only. The capsulorhexis was fitted with a Mini Capsulorhexis Valve (MCV). Follow up was done at 1, 7, 14, 21, 28 and 35 days when animals were euthanized, enucleated, Miyake view and histopathology analyses performed. Rabbits were treated with one of the following: SHA (control), mitomycin-C (0.2mg/ml), EDTA (10mM and 15mM), 5-flurouracil (5-FU, 33mg/ml), and 0.003% acetic acid. Results:Upon completion of study all treated eyes had PCO and new lens material. In some eyes PCO was localized in the center of the capsule surrounded by new lens material. Anterior capsular proliferation was observed in eyes treated with 5-FU. The order of PCO appearance (earliest to latest) is as follows: control, acetic acid, mitomycin-C, 5-FU, EDTA10mM and EDTA 15mM. The earliest being POD 7, the latest POD 21. Edema around surgical incision was present only in eyes treated with acetic acid (1 POD) and EDTA 15mM (POD 1 and POD 7). Mild intraocular inflammation was present in eyes treated with EDTA 10mM and moderate in eyes treated with EDTA 15mM and acetic acid at POD 1. Conclusion:EDTA 10mM and 15mM seem to be more efficient in retarding the appearance of PCO using the fore mentioned technique. Two factors which might have contributed to PCO development in treated eyes are rabbit’s ability to regenerate lens and the high rate of Lens Epithelial Cell (LEC) proliferation in young rabbits. Additional studies are needed to determine which drugs are more efficient in preventing or delaying the appearance of PCO. Support: Henri and Flore Lesieur Foundation; the Florida Lions Eye Bank; Research to Prevent Blindness; Australian Cooperative Research Centre (CRC) Scheme, CRC for Eye Research and Technology, Sydney.

Keywords: 522 posterior capsular opacification (PCO) • 390 drug toxicity/drug effects • 338 cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×